Maxidex

Dexamethasone, the active ingredient in Maxidex, is a corticosteroid presented as an ophthalmic solution for ocular use. It reduces inflammation in the eye and is employed to manage post‑operative ocular inflammation, uveitis, allergic conjunctivitis and other inflammatory eye conditions.

GNH USA supplies Maxidex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand. Our distribution network ensures reliable delivery across Europe, Asia, Africa and the Americas.

Maxidex, a glucocorticoid ocular anti‑inflammatory, is used to treat several inflammatory eye conditions. - Post‑operative ocular inflammation: reduces swelling and pain after eye surgery. - Uveitis: controls intra‑ocular inflammation and prevents tissue damage. - Allergic conjunctivitis: alleviates redness, itching and swelling caused by allergens. - Other inflammatory eye conditions: manages conditions such as iritis and scleritis by suppressing inflammation.

Adverse ocular and systemic reactions may occur with Maxidex use.

Common Side Effects: - Burning or stinging sensation upon instillation. - Blurred vision temporarily after dosing. - Increased intra‑ocular pressure in susceptible patients. - Mild eye irritation or redness.

Serious or Rare Side Effects: - Secondary ocular infection (bacterial, fungal or viral). - Persistent elevation of intra‑ocular pressure leading to glaucoma. - Cataract formation with prolonged use. - Hypersensitivity reactions such as eyelid edema or rash.

Before prescribing Maxidex, clinicians should consider several safety measures. - Assess intra‑ocular pressure: monitor IOP before and during therapy. - Screen for ocular infections: avoid use in active viral or fungal eye infections. - Evaluate systemic corticosteroid exposure: consider cumulative steroid load in patients on systemic steroids. - Use with caution in glaucoma patients: risk of pressure increase. - Pregnancy and lactation: safety not established; weigh benefits against potential risks. - Store at room temperature: keep the bottle in the original packaging, protect from light and moisture.

Maxidex may interact with other ophthalmic or systemic agents.

Major Interactions (Avoid): - Concurrent use of potent topical NSAIDs: may increase risk of corneal ulceration. - Systemic CYP3A4 inducers: may reduce dexamethasone ocular concentrations.

Moderate Interactions (Monitor Closely): - Other intra‑ocular corticosteroids: additive IOP‑raising effect. - Anticholinergic eye drops: may affect pupil size and intra‑ocular pressure. - Systemic immunosuppressants: potential for enhanced immunosuppression. - Antiviral eye medications: possible reduced efficacy against viral replication.